Quarterly report pursuant to Section 13 or 15(d)

Equity (Details) - Schedule of stock option activity

v3.21.2
Equity (Details) - Schedule of stock option activity - Stock Options [Member]
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Equity (Details) - Schedule of stock option activity [Line Items]  
Number of Shares, Outstanding beginning balance | shares 815
Weighted Average Exercise Price, Outstanding beginning balance | $ / shares $ 21.53
Weighted Average Remaining Contractual Term, Outstanding beginning balance 8 years 6 months 3 days
Aggregate Intrinsic Value, Outstanding beginning balance, | $ $ 120
Number of Shares, Granted | shares 880
Weighted Average Exercise Price, Granted | $ / shares $ 6.43
Number of Shares, Exercised | shares (1)
Weighted Average Exercise Price, Exercised | $ / shares $ 6.69
Number of Shares, Cancelled | shares (268)
Weighted Average Exercise Price, Cancelled | $ / shares $ 19.65
Number of Shares, Outstanding ending balance | shares 1,426
Weighted Average Exercise Price, Outstanding ending balance | $ / shares $ 12.57
Weighted Average Remaining Contractual Term, Outstanding ending balance 8 years 6 months 18 days
Aggregate Intrinsic Value, Outstanding ending balance | $ $ 2,207
Number of Shares Exercisable | shares 337
Weighted Average Exercise Price, Exercisable | $ / shares $ 29.19
Weighted Average Remaining Contractual Term (in years), Exercisable 5 years 4 months 17 days
Aggregate Intrinsic Value, Exercisable | $ $ 134